申请人:Janssen Pharmaceutica N.V.
公开号:US04250176A1
公开(公告)日:1981-02-10
Novel 1-substituted 4-(diarylmethyl)piperazine derivatives having antianaphylactic and antihistaminic properties, in which the 1-substituent is optionally substituted 2(3H) benzimidazol-2-one, 2(3H) benzothiazol-2-one, or 2(3H) benzoxazol-2-one.
具有抗过敏和抗组胺作用的新型1-取代的4-(二芳基甲基)哌嗪衍生物,其中1-取代基可以是选择性地取代的2(3H)苯并咪唑-2-酮,2(3H)苯并噻唑-2-酮或2(3H)苯并噁唑-2-酮。